Top Orthopedic Shoe Brands for Ultimate Comfort and Support

For individuals seeking comfort and support in their footwear, orthopedic shoes have become increasingly popular, offering a perfect blend of style and functionality. These specialized shoes are designed to provide much-needed relief and support for people with foot-related issues, and several brands have emerged as leaders in this field. Renowned for their commitment to quality and innovation, these brands have consistently pushed the envelope in creating shoes that alleviate discomfort and promote better foot health. Whether you're dealing with plantar fasciitis, arthritis, or simply looking for enhanced comfort during daily activities, the following list will guide you to some of the best brands catering to these needs.

Illustration of orthopedic shoe

Best brands of orthopedic shoe in 2025

New Balance

New Balance is a renowned brand in the footwear industry, particularly notable for its significant market presence and commitment to quality. In 2022, New Balance achieved a record-high $4.23 billion in shoe revenue, with footwear accounting for 80% of the company's total revenue. The brand holds a 4% share of the global shoe market and a 10% share in the US market. New Balance has also made strides in sustainability, using 91% preferred leather and 64% preferred cotton in its manufacturing as of 2022, with a target of 100% by 2025. Its shoes are known for their average weight of 10.5 oz for men and 8.5 oz for women, and the brand has seen a balanced 50-50% share between its men and women user segments in 2022. Explore more on New Balance's shoe statistics.

Aetrex

Aetrex Worldwide Inc. is a leading producer of orthopedic shoes, renowned for its commitment to health and comfort. Founded in 1946, the company has grown into a global leader in pedorthic footwear and foot orthoses, with solutions for a wide range of foot conditions. Aetrex uses advanced foot scanning technology, having scanned over 50 million people to develop better-fitting footwear. Through its Apex division, Aetrex offers fashion-forward, therapeutic shoes that meet Medicare Therapeutic Shoe Bill requirements, ensuring both comfort and style for patients. The company is expected to contribute significantly to the global orthopedic shoes market, which is projected to grow at a CAGR of 7.64% from 2024 to 2032. For more information, visit their official website.

Birkenstock

Birkenstock has established itself as a leading producer of orthopedic shoes, renowned for its ergonomic footbed and high-quality materials. Since 2014, the company has experienced a compound annual revenue growth (CAGR) of 20%, with a significant surge of over 70% in revenue from 2020 to 2022. The brand's success is driven by its premium products, such as the Boston clogs, which have seen a 6% increase in unit sales and a 14% increase in average selling price. Birkenstock's direct-to-consumer revenue has grown by 29%, and the company has expanded its product range, with closed-toe shoes now representing about 25% of total sales, showcasing its adaptability and market responsiveness. The brand's strong performance is also reflected in its increased presence in the U.S. market, with a 21% year-over-year revenue increase in the Americas region. For more detailed statistics on Birkenstock's growth, visit their revenue growth chart.

Orthofeet

Orthofeet is a leading brand in the orthopedic footwear market, renowned for its comfortable and supportive shoes. The company's Ortho-Cushion(r) system enhances comfort and helps ease pain in the heel, ball of the foot, knees, hips, and back, making it ideal for conditions like flat feet, plantar fasciitis, bunions, arthritis, neuropathy, and diabetes. In October 2024, orthofeet.com generated a revenue of $14,047,737 with a conversion rate ranging from 3.50% to 4.00%, highlighting its strong market presence. The website experienced a 6.3% revenue growth over the preceding three months, indicating steady consumer demand. With over 113,373 transactions and 3,012,307 sessions, Orthofeet stands out among its competitors.

HOKA ONE ONE

HOKA ONE ONE has emerged as a leading producer of orthopedic shoes, known for its maximalist midsoles and plush cushioning, which provide superior comfort and support. Founded in 2009 by Nicolas Mermoud and Jean-Luc Diard, the brand has seen remarkable growth, crossing $1 billion in annual sales by 2023, with a compound annual growth rate of roughly 50% since 2018. HOKA's unique design appeals to a wide range of consumers, from professional athletes to casual joggers and those seeking relief from foot ailments like Plantar Fasciitis. The brand's favorability among U.S. adults is close to that of major brands like Nike, with 30% of aware consumers favorable towards HOKA. Its collaborations with podiatrists and strong digital presence further enhance its reputation for quality and reliability. Explore HOKA ONE ONE's best running shoes to find the ideal pair for your needs.

Vionic

Vionic is a leading brand in the orthopedic shoe market, renowned for its stylish and supportive footwear. Founded in 2007, Vionic has rapidly grown, with its Relax Slippers named one of "Oprah's Favorite Things" in 2016. The brand's Orthaheel Technology has been proven effective, with a study showing that Vionic contoured sandals improved heel pain symptoms by 68% in a 12-week trial. Vionic shoes, recommended by the American Podiatric Medical Association (APMA), are designed to provide essential stability and support. The company continues to innovate, integrating orthotic technology into various shoe designs, including sandals, sneakers, and athletic shoes. You can explore their stylish and supportive footwear on their official website.

Brooks

Brooks Running has solidified its position as a leading producer of high-quality orthopedic and performance running shoes, maintaining the No. 1 market share in adult performance running footwear at U.S. national retail for the 11th consecutive quarter. The brand achieved a significant milestone by surpassing $1 billion in global revenue by the end of Q3 2024, driven by a 10% year-over-year increase in North America and a 16% growth in its e-commerce channel. In the Asia Pacific - Latin America region, Brooks saw a 30% revenue increase, while in Europe, Middle East, and Africa, revenue grew by 10% with a 24% increase in direct e-commerce sales. The brand's popular models, such as the Ghost, Glycerin, and Adrenaline GTS, continue to drive strong demand, with Brooks holding half of the top 10 shoe styles at U.S. specialty retail. Brooks was also voted the top brand for both Training and Race Running Shoe categories in the 2024 Running USA Global Runner Survey. For more details on their achievements and products, visit Brooks Running's official site.

Dr. Comfort

Dr. Comfort is a renowned brand specializing in orthopedic, diabetic, and other medical condition footwear, offering superior comfort and protection with features like extra depth for orthotics, removable insoles, and wide toe boxes. Their shoes are designed for people with conditions such as neuropathy, bunions, and hammertoes, and are Medicare approved for diabetic care. Dr. Comfort's products are crafted with high-quality materials and handmade craftsmanship, ensuring both style and health benefits. Their range includes casual, athletic, dress, and boot styles, catering to various needs. The brand's commitment to comfort and health makes it a top choice in the orthopedic footwear market.

Mephisto

Mephisto is a renowned brand in the orthopedic shoe market, known for its high-quality, handcrafted footwear that provides exceptional comfort, stability, and durability. Founded in France in 1965 by Martin Michaeli, Mephisto has expanded globally, with its products sold in over 80 countries. The brand is highly recommended by orthopedic doctors and is recognized for its innovative technologies, such as the Soft-Air midsoles and Air Jet System, which enhance foot health and reduce joint strain. Mephisto's commitment to excellence has earned it numerous awards, including the "Oscar de l'Exportation" for outstanding exporting dynamism. With over 600 models available, Mephisto continues to set high standards in the footwear industry. For more information about the Mephisto shoes, visit their official blog.

ASICS

ASICS is renowned as one of the best producers of orthopedic shoes, particularly in the running shoe segment, where it holds a significant global market share of 9.9% in performance running footwear as of 2019. The brand is trusted for its high-quality, comfortable, and supportive shoes, such as the Novablast 5, which offers exceptional cushioning and stability. In 2022, ASICS generated $3 billion in footwear revenue, with performance running and core performance sports shoes being the top sales contributors. The brand's shoes are designed to cater to various running needs, including options for flat feet and overpronation. ASICS' global shoe market share, although at 0.79% in 2022, reflects its strong presence in the athletic footwear industry. You can find more details about their shoes statistics on this ASICS Shoes Statistics page.